Tumor-associated astrocytes mediate the transcriptional reprogramming in myeloid cells toward an anti-inflammatory phenotype and can directly inhibit the cytolytic lymphocytes by expressing PD-L1 and/or Fas ligand (FasL), thereby repressing anti-tumor immune functions [115]. Here, FASLG is linked to neoplasm.